Ensaio em fase de recrutamento = ; Ensaio a decorrer = ; Ensaio concluído = ; Financiado por um membro do IRDiRC = ; Membro de uma ERN =

Ensaio (s) clínico (s) nacional (is)

BELGICA

OOST-VLAANDEREN
GENT

Long Term Extension Trial of Setmelanotide (RM-493) for Patients Who Have Completed a Trial of Setmelanotide for the Treatment of Obesity Associated With Genetic Defects Upstream of the MC4 Receptor in the Leptin-melanocortin Pathway - BE

Ghent University Hospital - UZ Gent

Ghent University Hospital

Mais detalhes

ESPANHA

Madrid
MADRID

Setmelanotide (RM-493): Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity - ES

Hospital Infantil Universitario Niño Jesús

Servicio de Endocrinología, Crecimiento y Metabolismo

Mais detalhes

REINO UNIDO

West Midlands
BIRMINGHAM

Setmelanotide (RM-493) Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity

University Hospital Birmingham

Marshfield Clinic

Mais detalhes

BELGICA

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

RecSAMP: Metabotyping of Overweight and Obese Children Towards Early Detection of Insulin Resistance and Low-grade Inflammation by Means of a Rectal Sampler

Universitair Ziekenhuis Brussel

Endocrinologie

Mais detalhes